Folks, Vericel announced today that it received FDA Fast Track designation for its ixmyelocel‑T product for treatment of advanced heart failure due to dilated cardiomyopathy.
So why am I posting this news about Vericel on this board?
Let's compare Mesoblast to Vericel.
Back in April 2016, Vericel's ixmyelocel‑T product failed to meet it's secondary endpoints of heart-pumping efficiency and six-minute walking distance in the Phase 2b trial.
You read that right - it FAILED to meet it's secondary endpoints. And that was in the Phase 2b trial.
Plus, ixmyelocel‑T is autologous, which means it takes a patient's own stem cells.
As opposed to allogeneic, which is Mesoblast's products. Lookup the comparison advantages of allogeneic vs. autologous especially with respect to mass commercialization and ready, off-the-shelf availability.
Mesoblast's CHF therapy is light years ahead of Vericel's in its efficacy and commercial viability.
And Mesoblast is way past Phase 2 in CHF.
So. The. FDA. Just. Granted. Vericel. Fast. Track. Designation for its ixmyelocel‑T product.
Over and out.
Tick, tock, tick, tock..............
- Forums
- ASX - By Stock
- MSB
- Heart Failure
Heart Failure
-
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
IGO
IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
NVA
Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.11 |
Change
-0.015(1.33%) |
Mkt cap ! $1.261B |
Open | High | Low | Value | Volume |
$1.14 | $1.16 | $1.10 | $2.237M | 1.990M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 138637 | $1.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.11 | 46392 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 138077 | 1.105 |
30 | 206001 | 1.100 |
18 | 163654 | 1.095 |
13 | 172599 | 1.090 |
10 | 631070 | 1.085 |
Price($) | Vol. | No. |
---|---|---|
1.110 | 9843 | 7 |
1.115 | 59701 | 12 |
1.120 | 135716 | 12 |
1.125 | 60037 | 8 |
1.130 | 19197 | 3 |
Last trade - 10.49am 29/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |